Product Pathways
Products
BCP0032 Bortezomib
Bortezomib (PS-341, Velcade) is a potent proteasome inhibitor.
BCP0172 Butabindide oxalate
Butabindide oxalate is a selective and potent inhibitor of tripeptidyl peptidase II.
BCP0410 Atazanavir(BMS-232632)
Atazanavir (Reyataz, BMS-232632) is an antiretroviral drug of the protease inhibitor (PI) class.
BCP000696 Saquinavir mesylate
Inhibitor of human immunodeficiency virus (HIV) protease (Ki values are <0.1 and 0.12 nM for HIV-2 and HIV-1 protease respectively). Exhibits high antiviral activity and low cytotoxicity.
BCP000732 MLN2238,MLN 2238,MLN-2238
MLN-2238(1072833-77-2) is a potent reversible and specific β5 site of the 20S proteasome inhibitor with an IC50 value of 3.4 nM.
BCP000733 MLN9708,MLN-9708,MLN 9708
MLN9708(1201902-80-8) is an orally bioavailable second generation proteasome inhibitor with potential antineoplastic activity.
BCP000869 MG132/MG-132
MG132 is a potent cell-permeable proteasome and calpain inhibitor with IC50 of 0.1 and 1.2 ?M for the inhibition of proteasome and calpain
BCP000905 Carfilzomib
BCP001043 Ritonavir
BCP001139 Lopinavir
Lopinavir (ABT-378) is an antiretroviral of the protease inhibitor class. It is used as a fixed-dose combination with another protease inhibitor, ritonavir, under the trade names Kaletra (high-income countries) and Aluvia (low-income countries).
第一页 1 2 最后页 
 
Only for research purpose , not for human consumption Copyright©2012 ShangHai Biochempartner Co.,Ltd.